STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #615 by analyst upside · 2026-06-27
TECX
Tectonic Therapeutic, Inc.
Healthcare · Market Cap $604M · P/E 0x
ANALYST PRICE TARGET
+145.2%
implied upside to consensus target
Current Price $31.99
Consensus Target $78.44
Bull Target $101.0
Bear Target $60.0
Analysts Covering 9
ANALYST CONSENSUS - BUY
Strong Buy
2
Buy
7
Hold
0
Sell
0
52-Week Low $14.39
52-Week High $36.03
YTD Return +53.0%
FUNDAMENTALS
Market Cap $604M
P/E Ratio (TTM) N/A
Forward P/E -6.8x
EPS (TTM) $-4.46
PEG Ratio N/A
Dividend Yield N/A
Revenue (TTM) N/A
Profit Margin N/A
52-WEEK RANGE
52-Week Low $14.39
52-Week High $36.03
Current Price $31.99
Bear Target $60.0
Bull Target $101.0
● Now $31.99 ● Target $78.44
TRADING DATA
Avg Volume 192K
YTD Return +53.0%
Analyst Count 9
Consensus Buy
Upside to Target +145.2%
Last Updated 2026-06-27

ANALYST SUMMARY

Tectonic Therapeutic, Inc. (TECX) is currently trading at $31.99 with a Wall Street consensus price target of $78.44, implying potential upside of 145.2% over the next 12 months. 9 analysts currently cover TECX, with a consensus rating of Buy - 100% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $101.0, while the most cautious has a target of $60.0.

TECX operates in the Healthcare sector with a market capitalisation of $604M. The stock is up 53.0% year-to-date and is currently trading near the upper end of its 52-week range of $14.39 – $36.03.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

RECENT ANALYST CALLS

Upgrade/downgrade history for TECX, with each firm's 90-day track record across all stocks we track. See full firm rankings →

Raymond James ↑ Upgrade
Outperform → Strong Buy 2026-05-26 Building track record
Stifel ● Initiated
Buy 2026-04-14 Building track record
Truist Securities — Reiterated
Buy → Buy 2026-01-08 Building track record
Oppenheimer ● Initiated
Outperform 2025-09-03 14% win rate (7 calls)
Truist Securities ● Initiated
Buy 2025-07-21 Building track record
LifeSci Capital ● Initiated
Outperform 2025-06-06 Building track record
Mizuho — Reiterated
Outperform → Outperform 2025-05-15 Building track record
Mizuho ● Initiated
Outperform 2025-04-21 Building track record
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
49
out of 100
Coverage depth
18/30
Consensus clarity
4/30
Vote unanimity
25/25
Rating stability
2/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call - not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →